The Aeson Total Artificial Heart helped three people with heart failure and pulmonary hypertension become eligible for a ...
Bernstein research firm maintained a positive outlook on Eli Lilly (NYSE:LLY) shares, reiterating an Outperform rating and a price target of $1,100.00. The endorsement comes amid a complex narrative ...
Tectonic Therapeutic (NASDAQ:TECX) recently announced positive interim results from its phase 1b study using Fc-fusion protein TX45 for the treatment of patients with Group 2 pulmonary ...
In related news, Tectonic Therapeutics has been under scrutiny after Eli Lilly halted a phase 2 clinical trial for a drug similar to Tectonic's TX45. Despite this, Leerink Partners maintained ...
Hosted on MSN20d
Tectonic secures $185 million in private equity fundingThe capital is earmarked for the clinical development of Tectonic's TX45 and TX2100, as well as for enhancing their discovery platform, in addition to providing working capital and supporting ...
The capital raised will be utilized to advance the clinical development of key product candidates, TX45 and TX2100, as well as fund the discovery platform, which may accelerate the company’s ...
A single dose of the investigational therapy TX45 improved heart function and blood flow, or hemodynamics, in people with pulmonary hypertension and heart failure with preserved ejection fraction ...
Shares of Tectonic Therapeutic (NASDAQ:TECX) added ~40% in the premarket on Thursday after the cardiac medicines developer said that an early-stage trial for its lead candidate TX45 achieved its ...
Investing.com -- Shares of Tectonic Therapeutic, Inc. (NASDAQ: TECX) surged 40% following the announcement of encouraging interim data from a Phase 1b trial for its TX45 treatment in patients with ...
U.S. stocks traded higher this morning, with the Dow Jones gaining more than 100 points on Thursday. The Dow traded up 0.26% to 44,829.59 while the NASDAQ gained 0.75% to 19,779.27. The S&P 500 ...
Tectonic Therapeutic TX45 improved both left ventricular function and pulmonary hemodynamics in patients with Group 2 Pulmonary Hypertension in Heart Failure with preserved Ejection Fraction ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results